Synergy between sublethal doses of shikonin and metformin fully inhibits breast cancer cell migration and reverses epithelial-mesenchymal transition
Abolfazl Rostamian Tabari, Pegah Gavidel, Farzaneh Sabouni, Mossa Gardaneh
Topics & Concepts
CD44MetforminMCF-7ApoptosisEpithelial–mesenchymal transitionCancer researchCell growthChemistryCancer cellFlow cytometryPharmacologyCellCancerBiologyMedicineInternal medicineEndocrinologyImmunologyBiochemistryMetastasisHuman breastDiabetes mellitusBioactive Compounds and Antitumor AgentsMetabolism, Diabetes, and CancerCancer, Hypoxia, and Metabolism